ROS triggered local delivery of stealth exosomes to tumors for enhanced chemo/photodynamic therapy

J Nanobiotechnology. 2022 Aug 23;20(1):385. doi: 10.1186/s12951-022-01591-7.

Abstract

Background: Exosomes are recognized as effective platforms for targeted delivery for their high physicochemical stability and biocompatibility. However, most of the exosomes are inevitably and rapidly cleared by mononuclear phagocytic system (MPS) during cancer therapy. How to engineer exosome to enhance the delivery efficiency is being intensively explored. In this study, we have constructed mPEG2000-TK-CP05 decorated exosomes as effective delivery platforms to achieve enhanced photodynamic/chemical cancer therapy.

Results: Exosomes were coated with CP05-TK-mPEG2000, in which CP05 is a peptide with high affinity to exosomal CD63 and TK could be cleaved by ROS. The resulted exosomes, namely stealth Exo, were electroporated to load RB (photosensitizer Rose Bengal) and Dox (Doxorubicin). We verified that the Stealth Exo@RB (Stealth Exo additionally loaded with RB) could escape MPS while accumulate in the tumor region efficiently in the xenograft model when laser irradiation conducted locally. Additionally, we revealed that the Stealth Exo serves as an efficient platform for Dox delivery. Dox, together with the RB mediated photodynamic therapy induce tumor cell damage synergistically in the tumor region. Moreover, the proposed switchable stealth exosomes minimized the dose of toxic Dox and thus allowed robust tumor immune response.

Conclusions: Our results indicated that the proposed Stealth Exo greatly improves both the accessibility and efficiency of drug delivery, with minimal chemical or genetic engineering. The proposed Stealth Exo serve as a promising and powerful drug delivery nanoplatform in cancer treatment.

Keywords: Cancer; Exosomes; Photodynamic therapy; ROS-responsive; Targeted delivery.

MeSH terms

  • Cell Line, Tumor
  • Doxorubicin
  • Drug Delivery Systems
  • Exosomes*
  • Humans
  • Neoplasms* / drug therapy
  • Photochemotherapy*
  • Reactive Oxygen Species

Substances

  • Reactive Oxygen Species
  • Doxorubicin